Research Funding Board

Ongoing

A-T Children’s Project – Research Grant Program

• Due: LOI submission rolling
• Funding: Up to $75,000 per year
• Project period: 1 to 2 years
• Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
• Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.

Alexander von Humboldt Research Foundation – Humboldt Research Fellowship

• Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
• Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
• Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
• Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
• Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.

Allen Institute for AI – Allen AI Young Investigators

• • Due: Rolling

• Funding: $100,000
• Project period:  1 to 3 years
• Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
• Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)

• Due: Rolling
• Funding: $100,000 to $1M
• Project period:  1 to 2 years
• Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
• Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

• Due: Open
• Funding:Up to $1M
• Project period:  Up to 3 years
• Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
• Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals

• Due: Annually October 15 and April 15
• Funding: Up to $100,000 per year
• Project period:  1 to 2 years
• Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
• Eligibility: Researchers at all levels are eligible.

Boehringer Ingelheim U.S. – Investigator-InitiatedStudies(IIS)

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
• Eligibility: Intended for U.S. based researchers.

Brutten Family Foundation – Grants

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
• Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.

Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant

• Due: Rolling submission
• Funding: Up to $10,000
• Project period:  Not specified
• Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
• Eligibility: Researcher should have necessary data in hand at time of application submission.

Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award

• Due: LOI submission rolling
• Funding: Negotiable
• Project period:  Not specified
• Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
• Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.

Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants

• Due: January 1 (Round 1); July 1 (Round 2) annually
• Funding: $25,000-$50,000
• Project period: 1 to 2 years
• Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
• Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.

Cystic Fibrosis Foundation – Student Loan Repayment Program

• Due: During and up to 4 months after active award period
• Funding: $14,000 per year maximum
• Project period: One-time payment
• Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
• Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.

Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience

• Due: Rolling
• Funding: Stipend (amount not specified)
• Project period: 1 year
• Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
• Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.

Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $250,000
• Project period: 2 years
• Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
• Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.

Foundation for Anesthesia Education and Research (FAER) – Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $75,000
• Project period: 1 year
• Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
• Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.

Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant

• Due: Rolling
• Funding: $75,000
• Project period: 1 year
• Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.

Foundation for Peripheral Neuropathy – Peripheral Neuropathy Research

• Due: Rolling LOI submission
• Funding: Not specified
• Project period: Not specified
• Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
• Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.

Gateway for Cancer Research – GFCR Grant Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – SIO Integrative Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – NCI/SPORE Program

• Due: Rolling
• Funding: $200,000 to $800,000
• Project period: 2 to 5 years
• Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Immune Tolerance Network – Request for Applications

• Due: Open; Concept Proposals accepted year-round
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
• Note: ITN does not accept proposals for non-human or preclinical studies.

Lennox-Gastaut Syndrome (LGS) Foundation – Cure LGS 365 Research Grants

• Due: Open
• Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
• Project period: Not specified
• Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
• Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.

Michael J. Fox Foundation – Parkinson’s Disease Therapeutics Pipeline Program

• Due: Rolling pre-application
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
• Eligibility: Open to industry and industry-academia collaborations.

NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

• Due: Standard March dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.

NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
• Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.

NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.

NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population

• Due: Rolling through May 7, 2029
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
• Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.

National Institutes of Health – Career Development (K) Awards

• New Applications due: annually on June 12, October 12
• Renewal/Revision/Resubmission: annually on March 12, July 12, November 12

National Institutes of Health – Individual Fellowship (F) Awards

National Institutes of Health – NIH Small Grant Program (R03)

Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants

• Due: Rolling
• Funding: Up to $4,000
• Project Period: 6 months.
• Purpose: To fund statistical and/or publication support of active PeDRA Studies
• Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.

Rare Diseases Clinical Research Network – Congenital and Perinatal Infections Consortium Scholars Program

• Due: Rolling
• Funding: Not specified
• Project period: 2 years
• Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
• Eligibility: Applicants must be fellows or early-stage faculty.

Rare Diseases Clinical Research Network – Pichichero Family Foundation Research Award in Pediatric Infectious Diseases Request for Proposals

• Due: Rolling
• Funding: $50,000
• Project period: Up to 2 years
• Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
• Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.

Rare Diseases Clinical Research Network – VCRC-VF Fellowship Program

• Due: Rolling
• Funding: Not specified.
• Project period: 2 years
• Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
• Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.

Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
• Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

The Milbank Foundation – Grants

• Due: Open (LOIs required)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
• Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.

Tourette Association of America – Support for Research Consortia and Collaborative Research Projects

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
• Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.

W.K. Kellogg Foundation – Grants

• Due: Open (LOIs accepted at any time)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
• Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.

April

Burroughs Wellcome Fund – Climate Change and Human Health Seed Grants

• Due: April 24, 2025
• Funding: $2,500 to $50,000
• Project Period: Not specified; based on quarterly reviews
• Purpose: To foster collaboration between scholars working in largely disconnected fields (basic/early biomedical scientific approaches and ecological, environmental, geological, geographic, planetary-scale thinking, and with population-focused fields, including epidemiology and public health, demography, economics, and urban planning) to change the course of climate change’s impact on human health.
• Eligibility: Open to scientists at all levels.

International Headache Society – IHS Clinical and Basic Science Headache Research Fellowship Award

• Due: April 28, 2025
• Funding: £ 50,000
• Project Period: 1 year
• Purpose: To support innovative and impactful research from early career investigators, promote their career in the field of headache, and increase base knowledge of headache disorders. Projects for basic or clinical science headache research or a combination of basic and clinical research will be considered. One fellowship is specifically available for applicants from low- and middle-income countries (LMICs); two expert mentors are required for an LMIC fellowship.
• Eligibility: Applicant and mentor must be a member of IHS and be professionally involved in the treatment, research or management of headache disorders. Applicants should be within 6 years of completing training as an MD, PhD, or specialty training, not including non-professional periods.

International Anesthesia Research Society – IARS Mentored Research Award

• Due: April 30, 2025
• Funding: $175,000
• Project Period: 2 years
• Purpose: To support the development of promising investigators in anesthesiology and related sciences, and help them prepare to apply for independent research funding.
• Eligibility: Membership required. Investigators with less than 10 years post completion of clinical training or a PhD who have not yet established substantial independent research funding or who are initiating a new area of research may apply. 45% protected time required. Prior or current awardees of NIH R grants, NIH K grants, AHA Young Investigator Awards, VA Career Development Awards, or the equivalent, are not eligible.

May

American Heart Association Science – Pilot Grants to Explore the Use of the American Heart Association Protein Binding Atlas to Discover Novel Protein Interactions

• Due: May 1, 2025
• Funding: $100,000
• Project Period: Up to 1 year
• Purpose: To support innovative pilot projects focused on predicting and understanding protein-protein and protein-small molecule interactions involved in key biological processes associated with cardiovascular, kidney, and metabolic diseases, including obesity. Use of the AHA’s Protein Portal is encouraged for these projects.
• Eligibility: AHA research awards are limited to U.S.-based non-profit institutions. To learn more about eligibility, attend the informational webinar scheduled for February 12, 2025.

American Society of Hematology – ASH Scholar Award

• Due: May 1, 2025 (LOI)
• Funding: Up to $100,000
• Project Period: 2 to 3 years
• Purpose: To help new scientists transition from a research trainee to establishing and independent career in hematology research.
• Eligibility: Varies per award level. Membership required.
  Fellow Scholar Award applicants must be in mentored, postdoctoral training positions with five or fewer years of research experience post terminal doctoral degree completion.
  Fellow to Faculty Scholar Award applicants must be mentored, postdoctoral trainees with five to eight years of research experience following completion of their terminal doctoral degree and have no more than $150,000 annually in research funding.
  Junior Faculty Scholar Award applicants must have between eight and 13 years of research experience following completion of their terminal doctoral degree. Applicants with faculty level appointments must apply for this award.

American Society of Hematology – Bridge Grant

• Due: May 1, 2025
• Funding: $150,000
• Project Period: Not specified
• Purpose: To allow scientists to continue research projects while awaiting NIH R01 (or other R01-equivalent) award funding.
• Eligibility: Membership required. Designed for applicants who received a score for their NIH R01 grant application (submitted within the past 18 months) that have not yet been funded may apply (Alos for R01-equivalent grants). Applicants must hold a faculty position at an academic institution or the equivalent position at a non-profit research organization and have available no more than $500,000 annually in other research funding. See award description for recent expansion in eligibility requirements.

Pfizer – 2025 Headache Medicine Fellowship – US

• Due: May 4, 2025
• Funding: Up to $80,000
• Project Period: 1 year
• Purpose: To support fellowship programs at institutions with clinical training programs in regions where there are continued workforce challenges and that have a strong focus on clinical practice, research, and education to advance the understanding of headache medicine.
• Eligibility: This grant will be awarded to a U.S.-based academic institution with a fellowship program that includes independent research and a strong mentoring program. U.S. citizenship, permanent residency, asylum status, or appropriate non-immigrant visa status with authorization for U.S. employment is required. Fellows must have an MD or DO and be eligible to and plan to obtain a UCNS (United Council for Neurologic Subspecialties) certification after completing their fellowship. MDs and DOs with specialties outside of neurology may also apply.

The Mark Foundation for Cancer Research – Emerging Leader Award

• Due: May 5, 2025 (LOI)
• Funding: $750,000
• Project Period: 3 years
• Purpose: To support outstanding early career investigators conducting innovative, high-impact, high-risk projects in cancer research that are distinct from the foundation’s current research portfolio.
• Eligibility: PIs must hold an MD, PhD, or equivalent, be employed by a U.S. or Canadian non-profit academic institution and be three to eight years from the start of an independent faculty research appointment as of December 31, 2025. Additional funding might be available based on project milestones achieved.

Bristol Myers Squibb Foundation – Robert A. Winn Excellence in Clinical Trials: Career Development Award (Winn CDA)

• Due: May 12, 2025
• Funding: $240,000
• Project Period: 2 years
• Purpose: To support career development of early-stage physician scientists who are underrepresented in medicine or physicians who demonstrate commitment to increasing diversity in clinical research, and to becoming independent clinical trial investigators engaged in advancing health equity through research and mentoring.
• Eligibility: Candidates must hold an MD, MD/PhD, DO or DO/PhD and have earned a terminal degree or residency within the past 10 years, identify as a member of a racial/ethnic group underrepresented in medicine, or have a demonstrated commitment to increasing diverse patient participation in clinical trials. 40% protected time required. R01 or equivalent awardees not eligible. U.S. citizenship, permanent residency or H-1B or O-1 Visa required. Clinical areas of focus: Cancer, Cardiovascular Diseases, and Immunologic Disorders. Mentor required.

Patient-Centered Outcomes Research Institute (PCORI)  – Advancing the Science of Engagement in Research PCORI Funding Announcement — Cycle 2 2025

• Due: May 13, 2025 (LOI)
• Funding: Up to $1.5 million – $3 million
• Project Period: Up to 2 – 3 years
• Purpose: To support studies that focus on development and validation measures (to capture structure/context, process, and outcomes of engagement, for both stakeholders and investigators) and development and/or testing of engagement methods (to generate evidence on the most effective approaches for engagement in research and how effectiveness varies by context).
• Eligibility: Academic research, private sector, research, or study-conducting entities may apply if they are able to demonstrate capability to comply with PCORI’s research guidelines (including, but not limited to transparency and conflicts of interest requirements, compliance with methodology standards, data privacy protection, meeting ethical standards for research, and depositing de-identified data for data sharing use.

Wellcome – Mental Health Award: Advancing target validation for novel mental health drug discovery

• Due: May 14, 2025 (neuromatch registration deadline)
• Funding: Up to £1-5 million per project
• Project Period: 3-5 years
• Purpose: To provide funding for research teams who will integrate cutting-edge analytics of longitudinal datasets with experimental research that will lead to better ways of predicting the onset or progression of anxiety, depression and/or psychosis, as well as better targeted early interventions.
• Eligibility: Teams should Include collaborations between diverse and multidisciplinary teams covering mental health and data science expertise. See funding information for other requirements and more details.

American Association for Cancer Research – AACR-ALK Positive Lung Cancer Research Fellowship

• Due: May 15, 2025
• Funding:$130,000
• Project Period: 2 years
• Purpose: A joint effort with Exelixis to support a postdoctoral or clinical research fellow conducting ALK-positive lung cancer research and help them establish a successful career path in this field.
• Eligibility: Applicants must have a doctoral degree, (PhD, MD, MD/PhD, or equivalent completed within the past five years; degree must not have been conferred before September 1, 2020) in a related field and hold a mentored research position as a postdoctoral fellow, clinical research fellow, or equivalent at an academic, medical, or research institution. Mentor required.

American Orthopaedic Society for Sports Medicine – Steven P. Arnoczky Young Investigator Grant

• Due: May 15, 2025
• Funding: Up to$40,000
• Project Period: Not specified
• Purpose: To support early-career researchers (surgeons) doing clinical and basic science research to help them gain experience as a PI leading a team.
• Eligibility: An applicant must be an orthopedic surgeon who has completed an approved residency program or is currently a resident in an approved program and has not received more than $25,000 in funding from organizations external to their parent institution.

American Pancreatic Association – Young Investigator in Pancreatology Grant

• Due: May 15, 2025
• Funding: $100,000
• Project Period: Not specified
• Purpose: To enhance training and experience for investigators who are in the early stages of their career and advance the field of pancreatology through basic and translational research in pancreatitis or pancreatic cancer.
• Eligibility: Senior postdoctoral researchers, instructors, research associates and assistant professors, including clinical and research track faculty who have an MD, MD/PhD, PhD, or DVM may apply. Mentor required.
  APAF & IAP Grant: Co-sponsored by the International Association of Pancreatology for emerging international scientists located in the institutions outside North America.
  APAF & Pfizer Grant: For researchers studying clinical and scientific disparities in pancreatology (open to applicants at international and North American institutions through support from Pfizer Inc.).
  APAF Grants – To encourage research projects by the next generation of scientists with priority given to proposals related to pancreatitis and the relationship between pancreatitis and pancreatic cancer.

The Gerber Foundation – Research Grants: Fall Grant Round

• Due: May 15, 2025 (concept papers due)
• Funding: Up to $30,000; Up to $350,000
• Project Period: Up to 3 years
• Purpose: To support projects that will improve the nutrition, care and development of infants and young children from the prenatal year before birth to three years of age (proposals that can be easily and quickly implemented on a broad scale with a predictable time frame to clinical application).
• Eligibility: Varies per mechanism
  Major Research Awards – Up to $350,000 for experienced PIs
  Novice Awards – Up to $30,000 for physicians, PhD candidates, PharmD candidates, and other similar degree candidates in a residency, postdoctoral, or fellowship training program or those with no more than one year post training who have not been a recipient of a K01 award from the National Institutes of Health and have an assigned mentor for the project and a current development plan.

Alliance for Cancer Gene Therapy  – ACGT 2025 – Cinelli Family Foundation Investigator Award in Cell and Gene Therapy for Breast Cancer

• Due: May 16, 2025 (LOI)
• Funding: $500,000
• Project Period: Up to 3 years
• Purpose: To support cell and gene therapy research specifically in breast cancers. LOI must include an abstract of the proposed research and a current biographical sketch. Applications from biotechnology companies with an early-stage cell and gene therapy clinical asset for breast cancer will also be considered.
• Eligibility: Candidates must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty.

Alliance for Cancer Gene Therapy  – ACGT 2025 Investigator Award in Cell and Gene Therapy for Cancer

• Due: May 16, 2025 (LOI)
• Funding: $500,000
• Project Period: Up to 3 years
• Purpose: To support cell and gene therapy research specifically in gynecological cancers (ovarian, endometrial, cervical). LOI must include an abstract of the proposed research and a current biographical sketch.
• Eligibility: Candidates must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty.

Gilead – HBV B-PRO Request for Proposals (RFP): Evaluating Patient-Reported Outcomes Associated with HBV Treatment

• Due: May 19, 2025 (LOI)
• Funding: $200,000
• Project Period: 18 months
• Purpose: To support studies that utilize patient-reported outcomes along with clinical data as a tool to gain insight into the patients’ views on treatment experience, quality of life, and overall well-being to learn how hepatitis B virus (HBV) treatment affects their lives and influences perspectives on their healthcare and well-being.
  *Any project greater than $200,000 should be discussed with your Gilead Medical Science Liaison.
• Eligibility: Research must focus on at least one of the topic areas listed in the RFP related to treating chronic hepatitis caused by HBV.

Alliance for Cancer Gene Therapy – ACGT 2025 Investigator Award in Cell and Gene Therapy for Cancer

• Due: May 16, 2025 (LOI)
• Funding: $500,000
• Project Period: Up to 3 years
• Purpose: To support cell and gene therapy research specifically in gynecological cancers (ovarian, endometrial, cervical). LOI must include an abstract of the proposed research and a current biographical sketch.
  *Any project greater than $200,000 should be discussed with your Gilead Medical Science Liaison.
• Eligibility: Candidates must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty.

Alliance for Cancer Gene Therapy – ACGT 2025 – Cinelli Family Foundation Investigator Award in Cell and Gene Therapy for Breast Cancer

• Due: May 16, 2025 (LOI)
• Funding: $500,000
• Project Period: Up to 3 years
• Purpose: To support cell and gene therapy research specifically in breast cancers. LOI must include an abstract of the proposed research and a current biographical sketch. Applications from biotechnology companies with an early-stage cell and gene therapy clinical asset for breast cancer will also be considered.
  *Any project greater than $200,000 should be discussed with your Gilead Medical Science Liaison.
• Eligibility: Candidates must hold an MD, PhD, or equivalent degree and must be tenure-track or tenured faculty.

TSC Alliance – Early-Stage Investigator Research Grants

• Due: May 19, 2025 (LOI)
• Funding: $150,000
• Project Period: 2 years
• Purpose: To support research that addresses a high-priority area: 1) Understanding phenotypic heterogeneity in TSC, 2) Gaining a deeper knowledge of TSC signaling pathways and the cellular consequences of TSC deficiency, 3) Improving TSC models, or 4) Developing clinical biomarkers or patient-reported outcome measure for TSC.
• Eligibility: Applicants must have an M.D., Ph.D. or equivalent and be an independent researcher (may also be non-tenured faculty or staff), or equivalent level at a research institution or company.
  Wong Family Foundation Research Award – all epilepsy-focused Postdoctoral Fellowship and Research Grant applicants will automatically be considered for this scholarship.

TSC Alliance – Postdoctoral Fellowships

• Due: May 19, 2025 (LOI)
• Funding: $150,000
• Project Period: 2 years
• Purpose: To support any type of basic or translational research relevant to TSC that provides opportunity for the trainee’s professional growth.
• Eligibility: Applicants must have an M.D., Ph.D. or equivalent and be working with and mentored by a sponsor to do research related to TSC. PI must have been a member of the sponsor’s lab for at least 1 year.
  Wong Family Foundation Research Award – all epilepsy-focused Postdoctoral Fellowship and Research Grant applicants will automatically be considered for this scholarship.

Chan Zuckerberg Initiative – Global Science Scholars

• Due: May 27, 2025
• Funding: Varies per mechanism
• Project Period: Up to 2 years
• Purpose: A Chan Zuckerberg Biohub network and Stellar Science Foundation partnership to support international postdoctoral fellowship programs between the U.S. and Japan to advance excellence in bioengineering and biomedical research by supporting early-career researchers and help them in conducting groundbreaking science in U.S. and Japanese research labs.
• Eligibility: Applicants must have recently earned a doctoral degree conferred by July 1, 2025 and not prior to July 1, 2021.
  Global Scholars in residence in the U.S.: Applicant must hold an undergraduate or doctoral degree from a Japanese degree-granting institution and be eligible to receive a U.S. visa. Up $85,000 total per year for two years.
  Global Science Scholars in residence in Japan: Applicant must be eligible to receive a Japanese visa and must have received their undergraduate or doctoral degree from a U.S. degree-granting institution. Up to 1,498,000 JPY per year for 2 years.

Bill and Melinda Gates Foundation – Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing Phase II

• Due: May 31, 2025
• Funding: Up to $750,000
• Project Period: Up to 18 months
• Purpose: To support research that will catalyze and accelerate multiple, diverse, innovative bioprocessing approaches that hold the promise of low cost-of-goods mAbs.
  Option A: The development of a conceptual facility design, and (2) generation of bench or lab-scale process data with sufficient analytical data to demonstrate the ability to produce an antibody at a final drug substance cost-of-goods of $10 per gram that could meet requirements for human applications and would support a rigorous cost-of-goods assessment by a third-party organization. Option B: Further development funding for Proof of Concept for low cost-of goods drug substance.
• Eligibility: Individuals applying through a legally recognized corporate entity may apply. Scientists at all levels who have innovative ideas that support a final drug substance cost-of-goods previously stated may apply. Funding: Option A: Up to $750,000 for up to 18 months; Option B: funding evaluated on a per-project basis. Projects led by women / in collaboration with women-led organizations, and/or applications from / in collaboration with institutions based in low- and middle-income countries are encouraged.

Gladys Brooks Foundation – Grants for Hospitals and Clinics

• Due: May 31, 2025 (Grant Proposal Letter due)
• Funding: Not specified
• Project Period: Not specified
• Purpose: To support innovative projects in the fields of libraries, education, hospitals and clinics.
• Eligibility: Institutions and organizations which are tax exempt under section 501(c)(3) of the Internal Revenue Code and foundations that are not private are eligible.

June

American Cancer Society – ACS Grants

• Due: June 1, 2025
• Funding: Varies per mechanism
• Project Period: Varies per mechanism
• Purpose: To support innovative research, translational research, and development of early career research faculty (including newly independent faculty), postdoctorals and clinician-scientists pursuing a career in cancer research to advance treatment and care and improve outcomes. Awards available for mentored grants and independent grants.
• Eligibility : See specific award mechanism for details.
  Discovery Boost Grants (DBG) – for independent, appointed faculty at a U.S. academic institution (Up to $297k/2years).
  Mission Boost Grants (MBG) – for independent investigator at any level (with faculty appointment at a U.S. academic institution). Stage 1: Up to $297k/2 years; Stage 2: Up to $545k/18 months.
  Research Scholar Grants (RSG) – for early career scientists within first 10 years of their initial independent research career or full-time faculty appointment. Up to $215k/4 years.
  Postdoctoral Fellowships (PF) – for investigators with a doctoral degree obtained within last 4 years; U.S. citizen or non-citizen holding appropriate visa a time of application submission working at a U.S. academic institution or eligible non-profit. Progressive stipends ($66k $70k/year for up to 3 years).
  Clinician Scientist Development Grant (CSDG) – for early career scientists with doctoral degree and an active clinical license who participates in clinical care and works at a U.S. academic institution. R-level grant recipients not eligible. $135/year for 3 to 5 years.

Alex’s Lemonade Stand Foundation for Childhood Cancer – R Accelerated Award Grant

• Due: June 5, 2025
• Funding: $200,000 per year
• Project Period: 4 years
• Purpose: To support research conducted by early career scientists that seeks to advance ALSF’s mission to find cures and better treatments and less toxic therapies for childhood cancers.
• Eligibility: Applicants must have an MD, PhD, or MD/PhD, DO, MBBS or equivalent, be within ten years of their first faculty appointment at the Assistant Professor level, and be a first-time PI or co-PI of a pediatric cancer research-focused NIH R01 award or equivalent independent award. Institutional support required.

Gilead – SPEARHEAD 2.0 2025 RFP: Screening imPlEmentation and linkage to cARe in HEpAtitis Delta

• Due: June 6, 2025 (LOI)
• Funding: Up to $200,000*
• Project Period: 18 months
• Purpose: To support studies that seek to understand and address barriers to Chronic hepatitis delta virus (HDV) screening and linkage to care.
  *Any project greater than $200,000 should be discussed with your Gilead Medical Science Liaison.
• Eligibility: Research must focus on at least one or both or these areas: 1) Generate data to assess current HDV linkage to care practice, identify barriers, develop, and implement novel approaches to improve linkage to care and/or 2) Generate data to determine who should be tested or retested for anti-HDV and/or HDV RNA and the optimal timing for retesting to ensure accurate diagnosis.

William T. Grant Foundation – William T. Grant Scholars Program

• Due : June 11, 2025(Mentor and Reference Letter deadline);July 1, 2025(Application deadline)
• Funding: Up to $425,000
• Project Period: Over 5 years
• Purpose: To provide career development support for early-career researchers who have potential to become influential researchers, who have a track record of conducting high-quality research and show interest in pursuing a significant shift in their trajectories as researchers. Support includes 5-year research and mentoring plans that significantly expand researchers’ expertise in new disciplines, methods, and content areas.
• Eligibility: Applicants must be employed in tenure-track or career ladder positions, be nominated by their institutions, and have received their terminal degree within 7 years of submitting application. Non-U.S. applicants must conduct research that has compelling policy or practice implications for youth in the U. S.

Pfizer – Independent Medical Education (RFP); Novel Therapies for Relapsed/Refractory large B-Cell Lymphoma in Community Oncology Practice

• Due : June 12, 2025
• Funding: Up to $750,000
• Project Period: Up to 18 months
• Purpose: To support projects that focus on increasing community healthcare professional understanding and competence in the areas of treatment options for patients with relapsed/refractory(R/R) DLBCL, therapy management strategies to reduce toxicity and optimize outcomes for patients with R/R DLBCL and mechanisms of drug-resistance/loss of response with emerging treatments.
• Eligibility: Organizations submitting applications must be based in the U.S. Medical, nursing, allied health, and/or pharmacy professional schools; large and small hospitals and healthcare institutions; professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement are eligible to apply. Only accredited organizations can offer continuing education credit for this project.

Pfizer – Pfizer Fellowship Grant Request for Proposals: Sickle Cell Disease (SCD) Fellowship

• Due : June 12, 2025
• Funding: $80,000
• Project Period: Up to 1 year
• Purpose: To support institutions with independent research and established and emerging fellowship programs for hematologists specializing in treating adults with SCD with a strong focus on clinical practice, research, and education to increase understanding of SCD.
• Eligibility: This grant will be awarded to a U.S.-based academic institution with a fellowship program that includes independent research and a strong mentoring program. U.S. citizenship, permanent residency, asylum status, or appropriate non-immigrant visa status with authorization for U.S. employment is required.

Merck KGaA – GenScript Life Science Research Grant Program (LSRG Program)

• Due : June 15, 2025
• Funding: $100,000
• Project Period: 1 year
• Purpose: To help accelerate projects with potential for impact and breakthrough, by leveraging GenScript’s existing resources and capabilities.
• Eligibility: Projects must demonstrate strategic alignment with GenScript’s primary areas of scientific interest.

Research to Prevent Blindness – Grants

• Due : June 15, 2025 (Nomination forms due)
• Funding: Varies per mechanism
• Project Period: Varies per mechanism
• Purpose: RPB provides grants to high-performing U.S.-based ophthalmology departments and their faculty and, through some awards, to high-potential vision researchers in any U.S.-based institution of higher education.
• Eligibility: Varies per mechanism (see requirements)
  RPB International Research Collaborators Award – $75,000 for international research collaborations between researchers in the U.S. and abroad (awarded to U.S. based institutions); for full-time, primary academic position as Asst. Professor up to full Professor (MD, PhD, or MD/PhD) by time of application.
  RPB Career Development Award – Candidates must hold a full-time, primary academic appointment in ophthalmology up to and including Assistant Professor (appointed within the last 3 years); must be either a U.S. citizen or permanent resident by application deadline. MDs and MD/PhDs must devote at least 50% to research (60% protected time desirable).
  – The RPB / Tom Wertheimer Career Development Award in Data Science focuses on vision research involving artificial intelligence and/or data science to gain knowledge related to sight-threatening conditions.
  RPB Stein Innovation Award – $300,000 for candidates from any U.S. institution of higher education who hold a full-time, primary academic position as Associate Professor through full Professor (MD, PhD, or MD/PhD) in basic science or other relevant department conducting innovative vision research. Ophthalmology Chairs (including interim and acting) may nominate a candidate.

Alex’s Lemonade Stand Foundation for Childhood Cancer – 2025 ‘A’ Award Grant

• Due : June 16, 2025
• Funding: $800,000
• Project Period: Over 4 years
• Purpose: To support original projects by early career scientists seeking to establish a career in pediatric oncology research and find cures/better treatments for childhood cancers.
• Eligibility: Applicants must have MD, PhD, MD/PhD, DO, MBBS or equivalent and be within 5 years of their first faculty appointment at the Assistant Professor level. A mentor for the project, at the candidate’s institution (U.S.- or Canadian-based), and a minimum of 75% protected time is required. PIs of a K99/R00 or other independent nationally competitive award will not be eligible (candidates are allowed to have mentored career development grants during the ‘A’ Award period).

American Society of Echocardiography Foundation (ASE Foundation) – Early-career Development Grant for Echo Scientists (EDGES)

• Due : June 16, 2025
• Funding: Up to $25k
• Project Period: 1 year
• Purpose: To fund novel, studies conducted by early career scientists that address a clinical gap in cardiovascular ultrasound imaging through research that could have potential impact on clinical care and potential for stimulating future funding and career growth, and to foster partnerships between physicians, veterinarians, sonographers, engineers, and data scientists.
• Eligibility: Any eligible ASE member that has completed their terminal degree or training within seven years of submission deadline may apply (physicians, veterinarians, sonographers, other health care professionals).

Target ALS – Drug Discovery Consortia: Bringing New, Biologically Rational Targets to the ALS Clinical Pipeline

• Due : June 17, 2025 (LOI)
• Funding: $130,000 per lab, per year maximum
• Project Period: 2 years
• Purpose: To support collaborative work (involving 3-5 laboratories) on ALS biology aimed at developing novel ALS therapeutic targets. Up to $500,000 for a collaborative project.
• Eligibility: Each consortium must have at least one investigator from the biotech/pharmaceutical industry. All collaborators must provide a copy of the executed agreement between their institutions on data/IP sharing or provide a document confirming each Technology Transfer Office is aware of the collaborative project and the need to sign a data/IP sharing agreement as part of the full proposal.

Gateway for Cancer Research – Pfizer Fellowship Grant Request for Proposals

• Due : June 20, 2025 (LOI)
• Funding: $200,000 to $1.5 M
• Project Period: 2 to 5 years
• Purpose: To fund cancer research institutions worldwide, including, patient-centered research, early phase clinical trials, translational research, and integrative oncology research that pairs conventional therapies with evidence-based, complimentary therapies for all types of cancers.
• Eligibility: Funds awarded to institutions. Applicants must demonstrate their project’s alignment with GFCR’s mission.
  Grant types: Joint NCI/ SPORE/ P20 Program, Integrative Research, Joint Society for Integrative Oncology (SIO) Program (FGAs Reviewed Once Annually), Decentralized Clinical Trial Initiative (DCTI)

Pfizer – Pfizer Fellowship Grant Request for Proposals

• Due : June 20, 2025
• Funding: Up to $80,000
• Project Period: 1 year
• Purpose: To support institutions with independent research and strong fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers who are focused on clinical practice, research, and education to increase understanding of ATTR cardiac amyloidosis. Award funds one fellow.
• Eligibility: Emerging and established fellowships at accredited U.S.-based academic institutions will be considered. Clinical training may be included in the program but is not required. Fellow time spent in clinical setting that is supported by grant funds must not be billed as patient care.

Harrington Discovery Institute – Brain Health Medicines

• Due : June 30, 2025
• Funding: $100,000
• Project Period: 1 year
• Purpose: To provide support for researchers conducting innovative research aimed at treating, preventing, or curing Alzheimer’s disease and related dementias. Discoveries sought: any therapeutic modality, novel validated targets, and discoveries demonstrating rigorous science, creativity, innovation with potential for clinical impact. Second year renewal based on progress. Up to $400,000 available with appropriate justification.
• Eligibility: Applicants with an MD, PhD or equivalent degree who are faculty at an accredited academic medical center, university, or research institution in the U.S. Canada, or UK are eligible. The majority of the research must be conducted at the PI’s institution if the project involves collaboration.

July

American Thoracic Society – Partner Grants

• Due : July 1, 2025
• Funding: $50,000 to$100,000
• Project Period: 1 year
• Purpose: To support early career investigators.
• Eligibility: Varies per mechanism
  ATS/Alveolar Capillary Dysplasia (ACDMPV) Research Grant – Investigators at any stage of their academic career interested in ACDMPV research. Priority: projects focused on the potential treatment of ACDMPV, early detection, or diagnosis. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Grant partner: Alveolar Capillary Dysplasia Association. $100,000 for 1 year.
  ATS/Alpha-1 Foundation Young Investigator Grant in Alpha-1 Antitrypsin Deficiency – Early career investigators new to research and interested in pursuing Alpha-1 Antitrypsin Deficiency research, and investigators holding an MD, PhD, or equivalent degree conducting basic science, clinical research, or ethic, legal, or social issues studies related to AAT deficiency are eligible. Grant partner: ALPHA-1 Foundation. $50,000 for 1 year.
  ATS/Chiesi USA, Inc. Research Grant in Obstructive Lung Disease – Early career investigators interested in research that has a high potential to advance the understanding of obstructive lung disease through basic, translational, or clinical research. $50,000 for 1 year.
  Johnson & Johnson ATS Early Career Investigator Award in Pulmonary Vascular Disease – Early career investigators (junior faculty member up to and including the rank of assistant professor, a postdoctoral scholar, a doctoral candidate, or a fellow) conducting research aimed at understanding the pathways and pathophysiology of pulmonary vascular disease to improve treatment for patients with pulmonary hypertension are eligible. U.S. or Canadian citizenship, permanent residence and a firm commitment from an applicant’s U.S.- or Canadian-based home institution is required. $100,000 for 1 year.

Damon Runyon Cancer Research Foundation – Damon Runyon-Rachleff Innovation Award Stage 1

• Due: July 1, 2025
• Funding: Up to $400,000
• Project Period: Up to 2 years
• Purpose: To support the next generation of exceptional scientists with high-risk/high-reward ideas that have the potential to significantly impact understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. Up to 4 years of funding ($800,000 total) based on demonstrated progress in years 1 and 2.
• Eligibility: Applicant must be conducting independent research at an institution in the US, hold an MD, DO, PhD, or MD/PhD degree or equivalent and belong to one of the following categories: Tenure-track Assistant Professors, Clinical Instructors and Senior Clinical Fellows, of Distinguished Fellows. 80% protected time required.

Foundation for the Society for Maternal-Fetal Medicine – 2025 Foundation for SMFM/AAOGF Scholar Award

• Due: July 1, 2025
• Funding: Up to $150,000
• Project Period: Up to 3 years
• Purpose: To support scholarly development and advanced scientific training of future academic physician leaders in the field of Obstetrics and Gynecology.
• Eligibility: This scholarship Award is to be used in an academic Department of Obstetrics and Gynecology in the United States or Canada to provide research training and experience for a candidate of proven ability who exhibits significant talent, original thought and evidence of dedication to an academic career. Second- and third-year support based on progress and availability of funding.

North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) – Clinical Research/Innovation Awards/ Pilot Grants

• Due: July 1, 2025
• Funding: Up to $25,000
• Project Period: 1 year
• Purpose: To support innovative, pilot, and/or clinical projects in North America that address critical issues related to Celiac Disease and gluten-free diet management to improve diagnosis and treatment of Celiac Disease, facilitate development of innovative tools or technologies to improve disease management and advance nutrition care of patients and families of children with Celiac Disease.
• Eligibility: Applicants at any career level who hold an MD, PhD, or equivalent, an advance nursing degree (BSN with an MS/PhD), or a degree in Pharmacy, Physiotherapy, Dietetics/Nutrition, or Social Work and work full-time in a clinical or academic setting may apply. Postdoctoral fellows being mentored by an NASPGHAN member may also apply. Full membership in NASPGHAN, APGNN or CPNP for at least one year required.

North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) – NASPGHAN Foundation/QOL Medical, LLC Research Award for the Study of Disorders Associated with Carbohydrate Maldigestion/Malabsorption in Children

• Due: July 1, 2025
• Funding: Up to $150,000
• Project Period: 2 years
• Purpose: To support clinical, translational, laboratory, or quality improvement sciences studies focused on disorders of carbohydrate (CHO) maldigestion/malabsorption (primary or secondary) in children, and other conditions that may include lactose intolerance, congenital sucrose-isomaltase deficiency, congenital enteropathies that impact intestinal epithelial cell function, or inflammatory conditions affecting CHO absorption.
• Eligibility: NASPGHAN membership for at least 2 years required. Applicants must hold an MD, DO, PhD, MD/PhD or equivalent and be a faculty member at a North American University or research institute at time of application. Current awardees of other grants with overlapping focus are not eligible.

North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) – NASPGHAN Foundation Young Investigator Development Awards

• Due: July 1, 2025
• Funding: $150,000
• Project Period: 2 years
• Purpose: To support junior faculty research that has the potential to lead to an independent research career in pediatric gastroenterology, hepatology, or nutrition.
• Eligibility: NASPGHAN membership for at least 2 years required. Applicants must be an MD, DO, PhD, MD/PhD or equivalent full-time faculty at the Assistant Professor level or below at an academic institution. Applicants may not currently be more than 5 years from fellowship completion (7/1202 – 9/1/2025) or be an awardee of an NIH mentored grant or equivalent, NIH R01, or any equivalent Canadian or Mexican grant mechanism.
  – NASPGHAN Foundation/NASPGHAN George Ferry Young Investigator Development Award
  Awarded to support a meritorious clinical, quality improvement, translational or basic science research related to diseases of the gastrointestinal tract, liver, pancreas, or nutritional disorders of
  children.
  – NASPGHAN Foundation/Sanofi Young Investigator Development Award for the Study of Pediatric Eosinophilic Gastrointestinal Disorders
  Awarded to support a meritorious clinical, quality improvement, translational or basic science research project related to pediatric Eosinophilic Esophagitis or other Eosinophilic Gastrointestinal Disorders.

North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) – Mid-Career Award

• Due: July 1, 2025
• Funding: $100,000
• Project Period: 2 years
• Purpose: To support mid-career level faculty (holding a faculty appointment for at least 5 years at time of application) pursuing research in pediatric gastroenterology, hepatology, and nutrition. Applicants may submit proposals for a new project within an established area of research or a new or innovative research area that represents a departure from previously funded research.
• Eligibility: Applicants must hold an MD, PhD, or equivalent and be a full-time faculty member at an institution in North America. NASPGHAN membership for at least 2 years required. K grant awardees may apply during the last two years of their award. Recipients of an active R01 at time of application are not eligible.

U.S. Association for the Study of Pain (USASP) – 2025 USASP-MAYDAY Clinical/Translational Research Award

• Due: July 1, 2025
• Funding: Up to $50,000
• Project Period: 1 year
• Purpose: To support innovative projects designed to close the gap between knowledge and practice in pain treatment, and projects that build on the current knowledge base, that have potential to be developed into a larger application for extramural support from institutions such as NIH, DoD, CHS and others).
• Eligibility: For early career researchers (in the U.S. or Canada) within four years of their faculty appointment , except those who have received tenure at the time of submission. Applicants must demonstrate a commitment to the field of pain research. USASP membership required.

American Association for Thoracic Surgery (AATS) – International Clinical Fellowship in Thoracic Aortic Surgery

• Due: July 2, 2025
• Funding: 55,000 Euros
• Project Period: 1 year
• Purpose: To provide experience in aortic surgery for CT surgeons who don’t have any exposure to thoracic aortic surgery in their departments. This includes full clinical access (with a high-volume operating experience) during the duration of the program and full immersion in the institution’s cardiothoracic surgical department. A research component is strongly encouraged. The host institution is the University of Vienna, Department of Cardiac Surgery. Funding includes Austrian taxes, health insurance and all social benefits required by Austrian labor law.
• Eligibility: Cardiothoracic surgeons with no exposure in thoracic aortic surgery are eligible.

American Association for Thoracic Surgery (AATS) – AATS Thoracic Surgical Oncology Research Training Fellowship

• Due: July 2, 2025
• Funding: $100,000
• Project Period: 1 year
• Purpose: To provide an industry-academic clinical practicum to allow thoracic surgeons to train in clinical trial design, writing, endpoint selection and data interpretation and other important aspects of leading clinical trials.
• Eligibility: Candidates must have an academic appointment (resident, fellow, or new faculty member) be actively engaged in ACGME-approved or similar foreign training program in general surgery or in thoracic surgery prior to the start of the fellowship, with general thoracic surgery as their primary specialty. Fluency in English required. No citizenship requirements, however applicants who are not U.S. citizens or permanent residents must have visa status for the duration of the project that allows them to complete the fellowship at the onsite location of an AstraZeneca facility.

Gilead – Research Scholars

• Due: July 7, 2025
• Funding: Up to $180,000
• Project Period: 2 years
• Purpose: To support early career faculty conducting innovative research to incorporate new perspectives to advance scientific knowledge and promote progress in areas of unmet medical need.
• Eligibility: Intended for early career and junior faculty in the U.S. (who hold an MD, PhD or equivalent and received their initial faculty appointment within the last 5 years at a U.S.-based institution). A research mentor and 50% protected time required.

EMBO – Postdoctoral Fellowships

• Due: July 11, 2025
• Funding: Varies
• Project Period: 2 years
• Purpose: To support for excellent postdoctoral researchers throughout Europe and the world. EMBO provides grants for host institutions in EMBC Member States to issue employment contracts to EMBO Fellows. Fellows working in other countries than EMBC Member States will receive a stipend. Fellowship includes support for fellows with children.
• Eligibility: Applicants who are internationally mobile with PhDs conferred within the past two years and MDs with the appropriate research experience may apply. Late stage pre-doctoral candidates nearing completion of PhD may also apply but must provide their PhD degree before the fellowship start date and must start their fellowship within 9 months of the offer. First author publications (and first author referred pre-prints) will be reviewed as part of the assessment criteria.

The Leakey Foundation – Research Grants

• Due: July 15, 2025
• Funding: Up to $30,000
• Project Period: 1 year
• Purpose: To support studies by advanced doctoral students and postdoctoral researchers affiliated with a university or museum. Current funding focus areas include: Paleoanthropology of the Miocene, Pliocene, and Pleistocene, Primates, and modern hunter-gatherer groups. Up to $20,000 for predoctoral students.
• Eligibility: Advanced predoctoral degree students and postdoctoral researchers affiliated with a university are eligible.

Damon Runyon Cancer Research Foundation – Damon Runyon-Dale F. Frey Award for Breakthrough Scientists

• Due: July 15, 2025
• Funding: $100,000 (paid over 1 year)
• Project Period: Up to 2 years
• Purpose: To support the nation’s top postdoctoral fellow by enabling them to complete mentored training under a leading senior scientist and to encourage the pursuit of bold ideas.
• Eligibility: Damon Runyon Fellows in the last year of their fellowship, current fellows selected in November 2021, May 2022, and February 2023. Fellows who have terminated their awards early to accept an independent academic faculty position or other funding are eligible to apply.

Thrasher Foundation – E.W. “AI” Thrasher Awards

• Due: July 15, 2025 (concept submission)
• Funding: Up to $550,000
• Project Period: Up to 3 years
• Purpose: To provide opportunities for new scientists to gain the research experience in child health necessary to establish themselves as independent research scientists.
• Eligibility: Physicians in a residency/fellowship training program, or who completed that program no more than one year before the Concept Paper deadline and postdoctoral researchers who received their terminal doctoral degree no more than three years prior to Concept Paper deadline.

American Board of Psychiatry and Neurology, Inc. – ABPN Dorthea Juul, PhD, Education Research Award

• Due: July 28, 2025
• Funding: Up to$100,000
• Project Period: Up to 2 years
• Purpose: To support projects related to promoting lifelong learning and certifying psychiatrists and neurologists to high standards of expertise.
• Eligibility: Applicants must hold a faculty appointment in a Psychiatry or Neurology department at an LCME-accredited medical school. Non-faculty applicants must submit a chair-approved offer letter confirming a start date before January 1, 2026. MD and DO applicants must be certified by ABPN, participate in ABPN’s continuing certification program and hold an unrestricted license to practice medicine in a state, commonwealth, territory, or possession of the U.S.

August

American Academy of Osteopathy – Osteopathic Research Funding

• Due :August 1, 2025 (LOI)
• Funding: $10,000 per year
• Project Period: 1 year (up to 2 years with justification)
• Purpose: To support clinical and basic science research involving health care outcomes in the practice of osteopathic medicine, with an emphasis on the use of osteopathic manipulative treatment (OMT) in patient care. Research topics may include but are not limited to benchtop physiological models research, educational standards development, practice guidelines research, normative data collection and clinical research.
• Eligibility: No research level specified. Submission of full application is by invitation only after LOIs are reviewed.

American Hearing Research Foundation – AHRF Discovery Grants

• Due :August 15, 2025
• Funding: Up to $50,000
• Project Period: 1 year
• Purpose: To support studies that investigate various aspects of hearing and balance disorders associated with the inner ear. Special Interests: Causes of Sudden Hearing Loss and Menier’s Disease.
• Eligibility: Priority is given to early career investigators who need seed funding to generate preliminary data that can be used to apply for larger grants administered by the NIH or other entities.

Damon Runyon Cancer Research Foundation – Damon Runyon-St. Jude Pediatric Cancer Research Fellowship Award

• Due : August 15, 2025
• Funding: Stipend of $70,000 (slight increase each year)
• Project Period: Up to 4 years
• Purpose: To support individuals with innovative project ideas in basic or clinical research that have the potential to significantly impact the prevention, diagnosis, or treatment of one or more pediatric cancers.
• Eligibility: Candidates must hold an MD, PhD, MD/PhD, DDS, DVM, DO. Level 1 applicants: Basic and physician-scientist must have received their degrees no more than 18 months prior to the application deadline and have no more than 1 year working in their sponsor’s lab by application deadline. 100% protected time required. Level 2: physician-scientists with MD, MD/PhD, DDS, DVM, DO or equivalent must have completed residency and clinical training and be board eligible in the U.S. by award start date. 80% protected time required.

John Templeton Foundation – Life Sciences Research RFPs

• Due : August 15, 2025 (Online Funding Inquiry (OFI))
• Funding: Not specified
• Project Period: Not specified
• Purpose: To support novel and fundamental on a broad range of areas and topics, including origins of life, complexity, emergence, evolution, human development, and ecological health and interventions. Areas of interest: Science of Purpose; Epigenetic inheritance; other innovative ideas in basic research in the biological sciences, including evolution, human development, plant resilience, and ecological health and interventions.
• Eligibility: None specified. By invitation only after review of a submitted OFI.

Merck KGaA   – Research Grants

• Due : August 31, 2025
• Funding: Varies
• Project Period: Varies
• Purpose: To support innovative research in challenging areas of future importance.
• Eligibility: Scientists at any level affiliated with any research-based institution, university or company are eligible.
  Smart Consumables for Digital Integration in Biomanufacturing Processes – Up to 120,000 EUR per year for up to three years with potential further collaboration.
  Multi-purpose Micro-Physiological Systems – to improve translatability and reduce the use of animals in the testing of drug and chemical compounds. Grant will be negotiated on a case by case basis.

September

Cancer Research Institute – CRI Irvington Postdoctoral Fellowships

• Due: September 1, 2025
• Funding:stipend $74,000 year 1; $76k year 2; $78k year 3
• Project Period: Up to 3 years
• Purpose: To support hypothesis-driven, mechanistic studies by qualified early career scientists at leading universities and research centers worldwide, who seek training in fundamental immunology or cancer immunology.
• Eligibility: Applicants must have a doctorate degree with 5 or more years of relevant postdoctoral experience (M.D. applicants should not include years of residency in this calculation) and be working in areas directly related to immunology or cancer immunology at a non-profit institution. Completion of eligibility questionnaire required.
  Note: CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity
  CRI Immuno-Informatics Postdoctoral Fellowship

Benign Essential Blepharospasm Foundation – Research Grant

• Due: September 30, 2025
• Funding:stipend Up to $50,000
• Project Period: 1 year
• Purpose: To support research directly related to the cause of, treatments for, and complications resulting from treatments for benign essential blepharospasm or Meige Syndrome, both forms of cranial dystonia.
• Eligibility: Only applicants employed by an organization or institution within the U.S., Canada, or foreign countries where supervision of grant administration is possible are eligible.

North American Society For Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN) – Advanced Fellowships

• Due: September 30, 2025
• Funding: $75,000
• Project Period: 1 year
• Purpose: To support advanced training for one year in pediatric nutrition for a NASPGHAN member to gain focused clinical research experience.
• Eligibility: NASPGHAN membership for at least 2 years and a mentor is required.
  – NASPGHAN Foundation/Abbott Advanced Fellowship Training In Pediatric Nutrition – researchareas to include but are not limited to fetal growth and neonatal nutrition, typical development of feeding skills/behaviors and feeding disorders; nutritional aspects of eating disorders such as anorexia nervosa and bulimia; malnutrition and failure to thrive; nutrition education; nutrition in specific systemic diseases or clinical states such as cystic fibrosis, liver disease, intestinal failure, and organ transplantation; nutrition support; community nutrition; nutrition epidemiology; energy homeostasis; nutrition and the microbiome; micronutrient homeostasis; nutrigenomics; obesity; breast milk and breast feeding; and basic laboratory nutritional science.
  – NASPGHAN Foundation Advance Fellowship Training in Pediatric Endoscopy – for focused a research/and or quality improvement project in areas including but not limited to Endoscopic retrograde cholangiopancreatography (ERCP) with stenting and/or sphincterotomy, endoscopic ultrasound (EUS), advanced approaches to control GI bleeding (sclerotherapy, argon laser, clips, etc), transnasal endoscopy, peroral endoscopic myotomy (POEM), esophageal or intestinal stricture dilatation, pancreatic pseudocyst drainage, etc.

November

Aniara Diagnostica  – Coagulation Research Grant

• Due: November 1, 2025
• Funding: $20,000
• Project Period: 1 year
• Purpose: To support innovative research on coagulation/hematology. This year, Aniara is requesting proposals for projects that deal specifically with Ehlers-Danlos syndrome (EDS) and its effects on hemostasis and thrombosis.
• Eligibility: Established researchers (PhD faculty or equivalent), student or trainee at an academic organization or institution in North America or Scandinavia. Applicants with a minimum of three peer-reviewed publications preferred.

Cystic Fibrosis Foundation – Medical Resident Research Award

• Due: November 14, 2025
• Funding: Up to $10,000
• Project Period: 1 year
• Purpose: To introduce residents to research through participation in a CF-relevant research project and to spark interest in a career in CF research or as a CF care provider. Priority will be given to projects that will lead to increased understanding of disease mechanisms, pathophysiology, and prevention, and the development of treatment strategies.
• Eligibility: U.S. citizens, permanent residents, or non-U.S. citizens working in a U.S.-based, non-profit or academic institution. Applicants must have completed medical training, hold an MD, DO, or equivalent, and be enrolled in an ACGME accredited residency program in the U.S. for the duration of the award. International applicants must be able to obtain the appropriate visas for application and be certified by the Educational Commission for Foreign Medical Graduates (ECFMG).

Cancer Research Institute – CRI Technology Impact Award

• Due: November 15, 2025 (LOI)
• Funding: $300,000
• Project Period: 2 years
• Purpose: To support collaborations between technology, developers and clinical cancer immunologists to generate proof-of-principle of a novel platform technology in bioinformatics that can accelerate the field’s efforts in developing immunotherapies that are effective for all cancer patients.
• Eligibility: Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation or provide documentation from their institution along with the Letter of Intent confirming they will hold the position of assistant professor or higher by the time of award start date.

December

American Cancer Society – Research Scholar Grants

• Due : December 1, 2025
• Funding: Up to$215,000 per year
• Project Period: Up to 4 years
• Purpose: To support independent, self-directed researchers working at an U.S. academic institution or eligible non-profit organizations.
• Eligibility: Awards available to support investigators at all levels who have been appointed as independent, full-time faculty less than 10 years ago. Applicant’s institution must provide space and other resources needed by independent investigators.

American Cancer Society – RFA: Leukemia Exploration and Prevention Grant Program (LEAP)

• Due : December 1, 2025
• Funding: Up to $430,000 per year
• Project Period: Up to 4 years
• Purpose: RUNX1 Research Program and the American Cancer Society (ACS) have partnered to support projects that deepen our understanding of the mechanisms that cause each leukemogenic step (projects should consider experimental designs that address both cell-autonomous and cell-nonautonomous factors), and projects that are high-risk with strong scientific rationale to pursue a cancer interception treatment.
• Eligibility: PIs/teams must work at a U.S. academic institution or eligible non-profit organization and can be full-time independent investigators at any career stage.
  LEAP-Research Scholar Grant – supports an independent research project (up to $215,000 per year for independent, self-directed researchers).
• LEAP Team Award – supports an interdisciplinary, synergistic team research project that will accelerate scientific advancement and clinical benefit (up to $430,000 per year).

Cancer Research Institute – Clinic & Laboratory Integration Program (CLIP)

• Due : December 1, 2025 (LOI)
• Funding: $300,000
• Project Period: 2 years
• Purpose: To support pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. In partnership with the Chordoma Foundation (CF), CRI also invites LOIs focused on topics related to accelerating the development of effective treatments and ultimately a cure for chordoma, a rare type of cancer that occurs in the bones of the skull base and spine.
• Eligibility: : Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher) at the time of award start date and be qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies.

Jay L. Smith Foundation – Grants

• Due : December 31, 2025 (pre-proposal)
• Funding: Not specified
• Project Period: 1 year
• Purpose: To support research, programs, education and outreach in various areas to include dementia & Alzheimer’s disease, health care access and delivery, elderly care, suicide prevention, and cancer research.
• Eligibility: U.S.-based nonprofit organizations may apply.

Awards

NOMIS & Science – Young Explorer Award

• Due : May 15, 2025
• Prize: Grand prize: $15,000; Runner(s) Up: $5,000 (plus 5-year digital subscription to Science and publication of essay).
• Purpose: Granted annually to recognize 1 bold young researcher who has performed interdisciplinary work involving cross-field collaboration; for high-risk research. The Grand Prize Award winner is automatically eligible to submit a funding proposal to the NOMIS board.
• Eligibility: Applicants must be thirty-five (35) years of age or younger and hold an MD, PhD or MD/PhD received within the last 10 years, at the time of entry. For early career scientists based on work done in the past 3 years.

Eppendorf & Science – Eppendorf & Science Prize for Neurobiology

• Due : June 15, 2025
• Prize: $25,000
• Purpose: To encourage and support research by promising early career scientists in neurobiology.
• Eligibility: Applicants must be early career scientists, no older than thirty-five (35) years of age and hold an MD, PhD or MD/PhD received within the last 10 years, at the time of entry. For early career scientists who have conducted outstanding research on methods of molecular, cellular, systems, or organic biology within the past 3 years.